Integrin Alpha-6 in Prostate Cancer Cell Dissemination: Genetic and Pharmacological Validation in Humanized Zebrafish Xenografts

Background: Dissemination makes prostate cancer lethal, and few therapies target it directly. Integrin alpha-6 (ITGA6) is a laminin-binding receptor cleaved by urokinase (uPA), which releases its extracellular domain and leaves a membrane-retained fragment, α6p. We hypothesized that ITGA6 and its cleavage are required for dissemination in tumor cells and host tissue. Methods: ITGA6 was knocked down and overexpressed in PC3 cells, and migration and morphology were measured in vitro. Proteins were assessed using immunostaining in PC3 and MDA-MB-231 cells (expression analysis only). Zebrafish xenografts tested loss and gain of function on angiogenesis and dissemination (ten or more labeled cells from the injection site). Cucurbitacin B (CuB), a pleiotropic compound reported to lower ITGA6, was tested to determine whether lowering ITGA6 lessens dissemination. Outcomes were reanalyzed with Fisher’s exact test, as were expression and outcome in TCGA cohorts (4273 tumors, nine types). Results: Knockdown reduced migration and dissemination in vivo. The host-supplied released extracellular domain displayed the strongest angiogenesis and dissemination, and a non-cleavable mutant reduced dissemination. CuB lowered ITGA6 protein levels and reduced dissemination. ITGA6 was expressed in all nine types, but bulk mRNA was not prognostic in the prostate or breast cohorts. Conclusions: In the PC3 model, ITGA6 and its cleavage regulate dissemination and angiogenesis in vivo. Blocking cleavage, most directly by antagonizing uPA, is a candidate strategy for testing in further models. Because CuB also acts on other pathways, its effects are consistent with, but do not prove, an ITGA6-mediated mechanism.

Authors

Institutions

Publication Details

Journal
Cancers
Published
2026-11-17
DOI
https://doi.org/10.3390/cancers18223677
Primary Topic
Cell Adhesion Molecules Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Integrin Alpha-6 in Prostate Cancer Cell Dissemination: Genetic and Pharmacological Validation in Humanized Zebrafish Xenografts

Zakir Khan, Ashley Williams, Vinoth Sittaramane, Louis Zehr et al.
Cancers
Cell Adhesion Molecules Research
article

Integrin Alpha-6 in Prostate Cancer Cell Dissemination: Genetic and Pharmacological Validation in Humanized Zebrafish Xenografts

Zakir Khan, Ashley Williams, Vinoth Sittaramane, Louis Zehr, Alexandra Griffis, Siddarth Srikumar, Chase Clark
article en

Abstract

Background: Dissemination makes prostate cancer lethal, and few therapies target it directly. Integrin alpha-6 (ITGA6) is a laminin-binding receptor cleaved by urokinase (uPA), which releases its extracellular domain and leaves a membrane-retained fragment, α6p. We hypothesized that ITGA6 and its cleavage are required for dissemination in tumor cells and host tissue. Methods: ITGA6 was knocked down and overexpressed in PC3 cells, and migration and morphology were measured in vitro. Proteins were assessed using immunostaining in PC3 and MDA-MB-231 cells (expression analysis only). Zebrafish xenografts tested loss and gain of function on angiogenesis and dissemination (ten or more labeled cells from the injection site). Cucurbitacin B (CuB), a pleiotropic compound reported to lower ITGA6, was tested to determine whether lowering ITGA6 lessens dissemination. Outcomes were reanalyzed with Fisher’s exact test, as were expression and outcome in TCGA cohorts (4273 tumors, nine types). Results: Knockdown reduced migration and dissemination in vivo. The host-supplied released extracellular domain displayed the strongest angiogenesis and dissemination, and a non-cleavable mutant reduced dissemination. CuB lowered ITGA6 protein levels and reduced dissemination. ITGA6 was expressed in all nine types, but bulk mRNA was not prognostic in the prostate or breast cohorts. Conclusions: In the PC3 model, ITGA6 and its cleavage regulate dissemination and angiogenesis in vivo. Blocking cleavage, most directly by antagonizing uPA, is a candidate strategy for testing in further models. Because CuB also acts on other pathways, its effects are consistent with, but do not prove, an ITGA6-mediated mechanism.

CancersVol. 18(22)
Duke University (US), Sam Houston State University (US), Georgia Southern University (US)
American Cancer Society, U.S. Department of Education
Good health and well-being
Cell Adhesion Molecules Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon